Beijing Easpring Material Technology Co., Ltd. (300073.SZ) Signs Strategic Cooperation Framework Agreement with Shandong Boyuan Pharmaceutical & Chemical Co., Ltd.

Stock News10-15

Beijing Easpring Material Technology Co., Ltd. (300073.SZ) announced that on October 15, 2025, the company (Party A) signed a Strategic Cooperation Framework Agreement with Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. ("Boyuan", Party B). Both parties have agreed to establish a long-term, comprehensive, and stable strategic cooperation relationship in the areas of solid lithium battery material technology development, product supply, market promotion, and equity investment. According to the agreement, both parties will collaborate on research and technology development in the field of solid lithium battery materials, leveraging Party A’s expertise in the large-scale preparation of sulfide electrolytes and customer channels and Party B’s advanced high-purity lithium iodide processing and industrialization capabilities to jointly develop new solid electrolyte products with high ionic conductivity and interfacial stability. They also agree to enhance their technological level and industrialization capabilities in the key material sector of solid-state batteries by sharing research and development platforms and forming technical teams to drive the iteration of sulfide-lithium iodide system technologies and customer integration.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment